T
600488
vs
S
Shanghai Composite
Over the past 12 months, Tianjin Tianyao Pharmaceuticals Co Ltd has underperformed Shanghai Composite, delivering a return of +0% compared to the Shanghai Composite's +26% growth.
Stocks Performance
600488 vs Shanghai Composite
Performance Gap
600488 vs Shanghai Composite
Performance By Year
600488 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Tianjin Tianyao Pharmaceuticals Co Ltd
Glance View
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research, development, production, and sales of corticosteroids and amino acid raw materials and preparations. The company is headquartered in Tianjin, Tianjin and currently employs 2,635 full-time employees. The company went IPO on 2001-06-18. The firm's primary products include corticosteroid bulk pharmaceutical chemicals (BPCs), amino acid BPCs and intermediate, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinolone acetate, prednisone acetate, triamcinolone acetonide, propranolol propionate and betamethasone, among others. The firm mainly distributes its products in domestic and overseas markets.